Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S.
Score another legal victory for Fonar. On March 21, the Melville, NY-based company announced that the $2.3 million judgment rendered against Fonar for independent service provider Magnetic Resonance Plus has been set aside. In its decision, the U.S. District Court for the southern district of New York also ordered a new trial, according to Fonar.
In December, a federal jury had awarded MR Plus $2.3 million, but the verdict was later overturned by the appeals court in January, which also reinstated Fonar's copyright-infringement and unfair-competition claims (SCAN 3/5/97).
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.